Furthermore, a high level of the hENT2 expression was correlated with advanced stages of several cancers including hepatocellular carcinoma, mantle cell lymphoma, and ovarian carcinoma [49]. This evidence concerns the gene SLC29A2 and mantle cell lymphoma.